ACIP Recommends Catch-Up HPV Vaccines Through Age 26
For adults aged 27 to 45 years, vaccination may be beneficial for some who are inadequately vaccinated.
Human Papillomavirus
Targeted Interventions Raise HPV Vaccine Acceptance in Women
Educational videos produced the highest rate of acceptability and knowledge.
HPV Vaccination Program Has Considerable Impact
Prevalence of HPV 16 and 18 decreased; anogenital wart diagnoses down in girls, women, boys, men.
Some Cervical Cancer Screening Strategies More Cost-Effective
Most lifetime QALYs seen with cytologic testing every 3 years, repeated for ASC-US.
Quadrivalent HPV Vaccine Less Effective in Immunocompromised Youth
Antibody titers to the HPV4 vaccine were lower for all HPV serotypes in individuals who were infected with HIV perinatally than those who were exposed to HIV perinatally.
Primary Cervical Screening for High-Risk HPV May Improve Detection
Compared with liquid-based cytology, routine primary hrHPV screening better detected cervical intraepithelial neoplasia grade 3 or worse and cervical cancer.
Inaccurate Parental Reporting of HPV Vaccination Linked to Multilevel Sociodemographic Factors
Parents of racial or ethnic minority adolescents were more likely to inaccurately report HPV vaccination initiation.
Many Teens Not Up to Date on HPV Vaccination
Only 15.7 and 34.8% of teens completed HPV vaccination before turning 13 and 15.
Prevalence of Anogenital Warts Declining Across Populations
The prevalence of anogenital warts has decreased, with significant declines observed in specific populations.
Self-Sampling Strategy to Encourage Screening for High-Risk Human Papillomavirus
Women who used a self-screening assay for high-risk human papillomavirus had similar test results to those who were screened by a clinician.
